The impact of initial statin treatment decisions on cardiovascular outcomes in clinical care settings: estimates using the Archimedes Model | Zendy

Andrew van Herick | Zendy; Schuetz | Zendy; Alperin | Zendy; Bullano | Zendy; Balu | Zendy; Sanjay Gandhi | Zendy

Open Access

The impact of initial statin treatment decisions on cardiovascular outcomes in clinical care settings: estimates using the Archimedes Model

Author(s) -

Andrew van Herick,

Schuetz,

Alperin,

Bullano,

Balu,

Sanjay Gandhi

Publication year - 2012

Publication title -

clinicoeconomics and outcomes research

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.591

H-Index - 27

ISSN - 1178-6981

DOI - 10.2147/ceor.s35487

Subject(s) - medicine , statin , intensive care medicine , hydroxymethylglutaryl coa reductase inhibitors

Many patients treated for dyslipidemia do not achieve recommended cholesterol goals despite the widespread availability of effective statins. Pharmaceutical claims show a strong tendency for patients to remain on their initially assigned treatment. With computer simulations, the impact of initial statin treatment decisions on medium- and long-term cardiovascular outcomes were examined.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research